Mednax Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $12.53
- Today's High:
- $12.87
- Open Price:
- $12.79
- 52W Low:
- $12.53
- 52W High:
- $19.63
- Prev. Close:
- $12.76
- Volume:
- 394254
Company Statistics
- Market Cap.:
- $1.07 billion
- Book Value:
- 11.403
- Revenue TTM:
- $2.00 billion
- Operating Margin TTM:
- 9.15%
- Gross Profit TTM:
- $467.03 million
- Profit Margin:
- 5.16%
- Return on Assets TTM:
- 4.88%
- Return on Equity TTM:
- 10.66%
Company Profile
Mednax Inc had its IPO on 1995-09-19 under the ticker symbol MD.
The company operates in the Healthcare sector and Medical Care Facilities industry. Mednax Inc has a staff strength of 5,250 employees.
Stock update
Shares of Mednax Inc opened at $12.79 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $12.53 - $12.87, and closed at $12.61.
This is a -1.18% slip from the previous day's closing price.
A total volume of 394,254 shares were traded at the close of the day’s session.
In the last one week, shares of Mednax Inc have slipped by -9.74%.
Mednax Inc's Key Ratios
Mednax Inc has a market cap of $1.07 billion, indicating a price to book ratio of 1.4995 and a price to sales ratio of 0.6423.
In the last 12-months Mednax Inc’s revenue was $2.00 billion with a gross profit of $467.03 million and an EBITDA of $218.51 million. The EBITDA ratio measures Mednax Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Mednax Inc’s operating margin was 9.15% while its return on assets stood at 4.88% with a return of equity of 10.66%.
In Q2, Mednax Inc’s quarterly earnings growth was a positive 6.8% while revenue growth was a positive 3%.
Mednax Inc’s PE and PEG Ratio
- Forward PE
- 8.4674
- Trailing PE
- 11.292
- PEG
- 0.88
Its diluted EPS in the last 12-months stands at $1.13 per share while it has a forward price to earnings multiple of 8.4674 and a PEG multiple of 0.88. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mednax Inc’s profitability.
Mednax Inc stock is trading at a EV to sales ratio of 1.023 and a EV to EBITDA ratio of 10.6604. Its price to sales ratio in the trailing 12-months stood at 0.6423.
Mednax Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.31 billion
- Total Liabilities
- $320.32 million
- Operating Cash Flow
- $-21748000.00
- Capital Expenditure
- $8.13 million
- Dividend Payout Ratio
- 0%
Mednax Inc ended 2024 with $2.31 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.31 billion while shareholder equity stood at $942.38 million.
Mednax Inc ended 2024 with $0 in deferred long-term liabilities, $320.32 million in other current liabilities, 838000.00 in common stock, $-46575000.00 in retained earnings and $1.53 billion in goodwill. Its cash balance stood at $5.85 million and cash and short-term investments were $104.34 million. The company’s total short-term debt was $36,486,000 while long-term debt stood at $666.27 million.
Mednax Inc’s total current assets stands at $397.77 million while long-term investments were $0 and short-term investments were $98.49 million. Its net receivables were $270.85 million compared to accounts payable of $30.99 million and inventory worth $12.46 million.
In 2024, Mednax Inc's operating cash flow was $-21748000.00 while its capital expenditure stood at $8.13 million.
Comparatively, Mednax Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $12.61
- 52-Week High
- $19.63
- 52-Week Low
- $12.53
- Analyst Target Price
- $15.75
Mednax Inc stock is currently trading at $12.61 per share. It touched a 52-week high of $19.63 and a 52-week low of $19.63. Analysts tracking the stock have a 12-month average target price of $15.75.
Its 50-day moving average was $14.03 and 200-day moving average was $14.55 The short ratio stood at 10.87 indicating a short percent outstanding of 0%.
Around 236.9% of the company’s stock are held by insiders while 10503% are held by institutions.
Frequently Asked Questions About Mednax Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.